|
|
.
See Category: Diseases of the eye and adnexa
See Header: Retinal neovascularization, unspecified
ICD-10 (CM) Code and Descriptor
|
H35.051 |
Retinal neovascularization, unspecified, right eye
|
H35051 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.22%
|
25.35%
|
11.58%
|
4.51%
|
2.31%
|
1.27%
|
0.94%
|
0.51%
|
0.35%
|
0.20%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H35.051*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
1,714
|
1,714
|
|
67028
|
INJECTION EYE DRUG |
1,702
|
1,702
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
975
|
978
|
|
C9257
|
BEVACIZUMAB INJECTION |
967
|
4,823
|
|
J0178
|
AFLIBERCEPT INJECTION |
555
|
1,150
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
224
|
224
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
133
|
133
|
|
J2778
|
RANIBIZUMAB INJECTION |
128
|
569
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
77
|
77
|
|
J9035
|
BEVACIZUMAB INJECTION |
71
|
103
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
67
|
67
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
48
|
48
|
|
99211
|
OFF/OP EST MAY X REQ PHY/QHP |
40
|
40
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
39
|
39
|
|
99212
|
OFFICE O/P EST SF 10 MIN |
29
|
29
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
28
|
28
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
28
|
64
|
|
J7999
|
COMPOUNDED DRUG, NOC |
19
|
79
|
|
67228
|
TREATMENT X10SV RETINOPATHY |
19
|
19
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
17
|
17
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H35.051 related to the following DRG Codes:
124-125
|
